Successful Percutaneous Dihydrotestosterone Treatment of Gynecomastia Occurring during Highly Active Antiretroviral Therapy: Four Cases and a Review of the Literature | Zendy

Olivier Benveniste | Zendy; Anne Legmann Simon | Zendy; Serge Herson | Zendy

Open Access

Successful Percutaneous Dihydrotestosterone Treatment of Gynecomastia Occurring during Highly Active Antiretroviral Therapy: Four Cases and a Review of the Literature

Author(s) -

Olivier Benveniste,

Anne Legmann Simon,

Serge Herson

Publication year - 2001

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/322637

Subject(s) - gynecomastia , medicine , antiretroviral therapy , percutaneous , dihydrotestosterone , human immunodeficiency virus (hiv) , dermatology , surgery , urology , virology , androgen , viral load , hormone

Fourteen cases of gynecomastia occurring during highly active antiretroviral therapy (HAART) have been reported in the literature. To date, no specific therapeutic approach has been proposed, and gynecomastia has usually persisted. We report 4 new cases of HAART-induced gynecomastia that were successfully treated with percutaneous dihydrotestosterone gel.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research